Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids

Chemico-Biological Interactions

Volumn 114, Issue 1-2, 1998, Pages 61-76

  Pereira, Elene ^a   Tarasiuk, Jolanta ^a   Garnier Suillerot, Arlette ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Doxorubicin anthracycline; Multidrug resistance; P glycoprotein; Vinca alkaloids

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; GLYCOPROTEIN P; IDARUBICIN; NAVELBINE; PIRARUBICIN; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINDESINE;

ARTICLE; CELL LEVEL; CELL STRAIN K 562; CONTROLLED STUDY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; SPECTROFLUOROMETRY;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; HYDROGEN-ION CONCENTRATION; IDARUBICIN; KINETICS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VINBLASTINE; VINCA ALKALOIDS; VINCRISTINE; VINDESINE;

EID: 0032479402     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00036-2     Document Type: Article

References (30)

1. Bradley G., Juranka P.F., Ling V. Mechanisms of multidrug resistance. Biochim. Biophys. Acta. 948:1988;87-128.
2. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
3. Beck W.T. The cell biology of multiple drug resistance. Biochem. Pharmacol. 18:1987;2879-2887.
4. Safa A.R. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl. Acad. Sci. 85:1988;7187-7191.
5. Safa A.R. Photoafinity labeling of P-glycoprotein in multidrug-resistant cells. Cancer Invest. 10:1992;295-305.
6. Beck W.T., Qian W.-D. Photoaffinity substrates for P-glycoprotein. Biochem. Pharmacol. 43:1992;89-93.
7. Tarasiuk J., Frezard F., Garnier-Suillerot A., Gattegno L. Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nulear concentration. Biochim. Biophys. Acta. 1013:1989;109-117.
8. Frezard F., Garnier-Suillerot A. Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells. Eur. J. Biochem. 196:1991;483-4911.
9. Frezard F., Garnier-Suillerot A. Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and -sensitive K562 cells. Biochim. Biophys. Acta. 1091:1991;29-35.
10. Tsuruo T., Saito H.J., Kawabata H., Oh-Hara T., Hamada H., Utakoji T. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and isolated clones. Jpn. J. Cancer Res. 77:1986;682-692.
11. Chaudhary P.M., Roninson I.B. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85:1993;632-639.
12. C. Marbeuf-Gueye, H.J. Broxterman, F. Dubru, W. Priebe, A. Garnier-Suillerot, Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells, Mol. Pharmacol. 53 (1998) 141-147.
13. Pereira E., Borrel M.-N., Fiallo M., Garnier-Suillerot A. Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells. Biochim. Biophys. Acta. 1225:1994;209-216.
14. Borrel M.-N., Fiallo M., Priebe W., Garnier-Suillerot A. P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells. FEBS Lett. 356:1994;287-290.
15. Mankhetkorn S., Dubru F., Hesschenbrouck J., Fiallo M., Garnier-Suillerot A. Relation among the resistance factor, kinetics of uptake and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, 8-(S)-fluoroidarubicin and idarubicin in multidrug-resistant cells. Mol. Pharmacol. 49:1996;532-539.
16. Bender R.A., Hamel E., Hande K.R. Chabner B.A., Collins J.M. Plant Alkaloids in Cancer Chemotherapy: Principles and Practice. 1990;253-275 Lippincott, Philadelphia, PA.
17. van Tellingen O., Sips J.H.M., Beijnen J.H., Bult A., Nooijen W.J. Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives. Anticancer Res. 12:1992;1699-1716.
18. Potier P. The synthesis of navelbine prototype of a new series of vinblastine derivatives. Semin. Oncol. 16:1989;2-4.
19. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:1989;137-174.
20. Higgins C.F., Gottesman M.M. Is the multidrug transporter a flippase? Trends in Biochem. Sci. 17:1992;18-21.
21. Altenberg G.A., Vanoye C.G., Horton J.K., Reuss L. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane. Proc. Natl. Acad. Sci. 91:1994;4654-4657.
22. Shalinsky D.R., Jekunen A.P., Alcaraz J.E., Christen R.D., Kim S., Khatibi S., Howell S.B. Regulation of initial vinblastine influx by P-glycoprotein. Br. J. Cancer. 67:1993;30-36.
23. Safa A.R., Glover C.J., Meyers M.B., Biedler J.L., Felsted R.L. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug resistance. J. Biol. Chem. 261:1986;6137-6140.
24. Broxterman H.J., Kuiper C.M., Schuurhuis G.J., Tsuruo T., Pinedo H., Lankelma J. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein. Biochem. Pharmacol. 37:1988;2389.
25. Domenech C., Fierro-Duran G., Leocadio R., Grau-Oliete M.R., Rivera-Fillat M.P. Vincristine cellular pharmacokinetic changes associated with multidrug resistance. Eur. J. Pharmacol. 248:1993;49-58.
26. Hunter J., Jepson M.A., Tsuruo T., Simmons N.L., Burst B.H. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268:1993;14991-14997.
27. Garnier-Suillerot A. Impaired accumulation of drug in multidrug resistant cells. What are the respective contributions of the kinetics of uptake and of P-glycoprotein-mediated efflux of drug? Curr. Pharm. Des. 1:1995;69-82.
28. Owellen R.K., Donigian D.W., Hartke C.A., Hains F.O. Correlation of biologic data with physicochemical properties among the vinca alkaloids and their congeners. Biochem. Pharmacol. 26:1977;1213-1219.
29. 3H]vinblastine from Chinese Hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene, Cancer Res. 49 (1989) 3867-3871.
30. Boman N.B., Mayer L.D., Cullis P.R. Optimization of the retention properties of vincristine in liposomal systems. Biochim. Biophys. Acta. 1152:1993;253-258.